Cyproheptadine Hydrochloride and Insulin glargine and lixisenatide
Determining the interaction of Cyproheptadine Hydrochloride and Insulin glargine and lixisenatide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cyproheptadine
Brand name: Periactin
Synonyms: Cyproheptadine
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cyproheptadine Hydrochloride-Insulin glargine and lixisenatide Subcutaneous
- Cyproheptadine Hydrochloride-Insulin glargine, recombinant Subcutaneous
- Cyproheptadine Hydrochloride-Insulin glulisine
- Cyproheptadine Hydrochloride-Insulin Glulisine (Cartridges and Pens)
- Cyproheptadine Hydrochloride-Insulin Glulisine (Vials)
- Cyproheptadine Hydrochloride-Insulin glulisine Subcutaneous
- Insulin glargine and lixisenatide-Cyproheptadine Solution
- Insulin glargine and lixisenatide-Cyproheptadine Syrup
- Insulin glargine and lixisenatide-Cyproheptadine Tablets
- Insulin glargine and lixisenatide-Cyramza
- Insulin glargine and lixisenatide-Cyred
- Insulin glargine and lixisenatide-Cyred EQ